Clinical Trials Browser

Phase 1 × Lymphoma, Extranodal NK-T-Cell × Asparaginase × Clear all

NCT04230330 2020-11-05

Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma

Phase 1 Withdrawn

Lymphoma, Extranodal NK-T-Cell